SVB WEALTH LLC - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 14 filers reported holding Astellas Pharma Inc in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SVB WEALTH LLC ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q3 2023$145,037
-19.3%
10,472
-13.3%
0.00%0.0%
Q2 2023$179,614
-2.6%
12,079
-7.0%
0.00%0.0%
Q1 2023$184,394
+9.8%
12,990
+17.3%
0.00%
+50.0%
Q4 2022$167,897
-67.2%
11,075
-64.2%
0.00%
-71.4%
Q3 2021$512,000
-8.9%
30,910
-4.5%
0.01%0.0%
Q2 2021$562,000
+166.4%
32,363
+135.5%
0.01%
+133.3%
Q1 2021$211,000
+13.4%
13,740
+14.2%
0.00%0.0%
Q4 2020$186,000
+9.4%
12,030
+5.1%
0.00%0.0%
Q3 2020$170,000
-15.4%
11,449
-5.0%
0.00%
-25.0%
Q2 2020$201,00012,0520.00%
Other shareholders
Astellas Pharma Inc shareholders Q4 2020
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 391,745$5,438,8800.25%
Cassady Schiller Wealth Management, LLC 698$9,6670.01%
MAI Capital Management 19,087$264,3620.00%
SVB WEALTH LLC 10,472$145,0370.00%
RHUMBLINE ADVISERS 34,759$481,4080.00%
First Horizon Advisors, Inc. 114$1,5780.00%
Operose Advisors LLC 90$1,2470.00%
Russell Investments Group, Ltd. 783$10,8450.00%
PNC FINANCIAL SERVICES GROUP, INC. 166$2,2990.00%
View complete list of Astellas Pharma Inc shareholders